146 related articles for article (PubMed ID: 35367833)
1. Hepatitis B virus-associated hepatocellular carcinoma with Smc5/6 complex deficiency is susceptible to PARP inhibitors.
Funato K; Otsuka M; Sekiba K; Miyakawa Y; Seimiya T; Shibata C; Kishikawa T; Fujishiro M
Biochem Biophys Res Commun; 2022 Jun; 607():89-95. PubMed ID: 35367833
[TBL] [Abstract][Full Text] [Related]
2. HBx-induced degradation of Smc5/6 complex impairs homologous recombination-mediated repair of damaged DNA.
Sekiba K; Otsuka M; Funato K; Miyakawa Y; Tanaka E; Seimiya T; Yamagami M; Tsutsumi T; Okushin K; Miyakawa K; Ryo A; Koike K
J Hepatol; 2022 Jan; 76(1):53-62. PubMed ID: 34478763
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5/6.
Rivière L; Quioc-Salomon B; Fallot G; Halgand B; Féray C; Buendia MA; Neuveut C
Antiviral Res; 2019 Dec; 172():104618. PubMed ID: 31600532
[TBL] [Abstract][Full Text] [Related]
4. PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles' heel?
Gerossier L; Dubois A; Paturel A; Fares N; Cohen D; Merle P; Lachuer J; Wierinckx A; Saintigny P; Bancel B; Selves J; Schnitzler A; Ouine B; Cartier A; de Koning L; Puard V; Bieche I; Hernandez-Vargas H; Hall J; Chemin I
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101553. PubMed ID: 33183998
[TBL] [Abstract][Full Text] [Related]
5. Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.
Pan MR; Hsieh HJ; Dai H; Hung WC; Li K; Peng G; Lin SY
J Biol Chem; 2012 Feb; 287(9):6764-72. PubMed ID: 22219182
[TBL] [Abstract][Full Text] [Related]
6. Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma.
Zai W; Chen W; Han Y; Wu Z; Fan J; Zhang X; Luan J; Tang S; Jin X; Fu X; Gao H; Ju D; Liu H
Carcinogenesis; 2020 May; 41(3):345-357. PubMed ID: 31175354
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication.
Murphy CM; Xu Y; Li F; Nio K; Reszka-Blanco N; Li X; Wu Y; Yu Y; Xiong Y; Su L
Cell Rep; 2016 Sep; 16(11):2846-2854. PubMed ID: 27626656
[TBL] [Abstract][Full Text] [Related]
8. New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors.
Liu FW; Tewari KS
Curr Treat Options Oncol; 2016 Mar; 17(3):12. PubMed ID: 26931795
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase activity and inhibition in cancer.
Dulaney C; Marcrom S; Stanley J; Yang ES
Semin Cell Dev Biol; 2017 Mar; 63():144-153. PubMed ID: 28087320
[TBL] [Abstract][Full Text] [Related]
11. Identification of critical residues in the regulatory protein HBx for Smc5/6 interaction and hepatitis B virus production.
He L; Shen H; Deng H; Zhang X; Xu Y; Shi C; Ouyang Z
Antiviral Res; 2023 Mar; 211():105519. PubMed ID: 36592669
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
Bryant HE; Helleday T
Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting of DNA damage repair pathways guided by homologous recombination deficiency scoring in ovarian cancers.
Lin C; Liu P; Shi C; Qiu L; Shang D; Lu Z; Tu Z; Liu H
Fundam Clin Pharmacol; 2023 Apr; 37(2):194-214. PubMed ID: 36130021
[TBL] [Abstract][Full Text] [Related]
14. Targeting DDX11 promotes PARP inhibitor sensitivity in hepatocellular carcinoma by attenuating BRCA2-RAD51 mediated homologous recombination.
Cao K; Wang R; Li L; Liao Y; Hu X; Li R; Liu X; Xiong XD; Wang Y; Liu X
Oncogene; 2024 Jan; 43(1):35-46. PubMed ID: 38007537
[TBL] [Abstract][Full Text] [Related]
15. LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL.
Parvin S; Ramirez-Labrada A; Aumann S; Lu X; Weich N; Santiago G; Cortizas EM; Sharabi E; Zhang Y; Sanchez-Garcia I; Gentles AJ; Roberts E; Bilbao-Cortes D; Vega F; Chapman JR; Verdun RE; Lossos IS
Cancer Cell; 2019 Sep; 36(3):237-249.e6. PubMed ID: 31447348
[TBL] [Abstract][Full Text] [Related]
16. Expression of human poly (ADP-ribose) polymerase 1 in Saccharomyces cerevisiae: Effect on survival, homologous recombination and identification of genes involved in intracellular localization.
La Ferla M; Mercatanti A; Rocchi G; Lodovichi S; Cervelli T; Pignata L; Caligo MA; Galli A
Mutat Res; 2015 Apr; 774():14-24. PubMed ID: 25779917
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathways: targeting PARP in cancer treatment.
Do K; Chen AP
Clin Cancer Res; 2013 Mar; 19(5):977-84. PubMed ID: 23269547
[TBL] [Abstract][Full Text] [Related]
18. Identifying and Characterizing Interplay between Hepatitis B Virus X Protein and Smc5/6.
Livingston CM; Ramakrishnan D; Strubin M; Fletcher SP; Beran RK
Viruses; 2017 Apr; 9(4):. PubMed ID: 28368357
[TBL] [Abstract][Full Text] [Related]
19. [From poly(ADP-ribose) discovery to PARP inhibitors in cancer therapy].
Schreiber V; Illuzzi G; Héberlé E; Dantzer F
Bull Cancer; 2015 Oct; 102(10):863-73. PubMed ID: 26384693
[TBL] [Abstract][Full Text] [Related]
20. BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency.
Sun C; Yin J; Fang Y; Chen J; Jeong KJ; Chen X; Vellano CP; Ju Z; Zhao W; Zhang D; Lu Y; Meric-Bernstam F; Yap TA; Hattersley M; O'Connor MJ; Chen H; Fawell S; Lin SY; Peng G; Mills GB
Cancer Cell; 2018 Mar; 33(3):401-416.e8. PubMed ID: 29533782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
